# FDA Inspection 1308704 - KLEB Inc - March 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/kleb-inc/e5e971ef-a499-4485-b079-21ef6776ff9d
Source feed: FDA_Inspections

> FDA Inspection 1308704 for KLEB Inc on March 17, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1308704
- Company Name: KLEB Inc
- Inspection Date: 2026-03-17
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Cincinnati District Office

## Related Documents

- [FDA Inspection 1216491 - 2023-08-24](https://www.keypedia.com/records/fda_inspections/kleb-inc/dcaa529d-a229-4fcf-821d-715f129ddef2)
- [FDA Inspection 1216491 - 2023-08-24](https://www.keypedia.com/records/fda_inspections/kleb-inc/18103889-255c-4a01-ac5c-c144e18c2573)
- [FDA Inspection 1148296 - 2021-07-28](https://www.keypedia.com/records/fda_inspections/kleb-inc/6b64f84e-df48-4265-9ef0-b9d2f8905d94)
- [FDA Inspection 1148296 - 2021-07-28](https://www.keypedia.com/records/fda_inspections/kleb-inc/5eb33116-6151-4d74-b940-6a263c5de080)
- [FDA Inspection 1148296 - 2021-07-28](https://www.keypedia.com/records/fda_inspections/kleb-inc/d2123276-91e0-400d-9846-e7c4d0673b04)

Company: https://www.keypedia.com/companies/kleb-inc/4a2a949f-8893-4a4c-afd4-87e1adea1607

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22